- Home
- CMPX vs LE Comparison
CMPX vs LE Comparison
Compare CMPX & LE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- LE
- Stock Information
- Founded
- CMPX 2014
- LE 1963
- Country
- CMPX United States
- LE United States
- Employees
- CMPX N/A
- LE N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- LE Clothing/Shoe/Accessory Stores
- Sector
- CMPX Health Care
- LE Consumer Discretionary
- Exchange
- CMPX Nasdaq
- LE Nasdaq
- Market Cap
- CMPX 229.5M
- LE 274.7M
- IPO Year
- CMPX N/A
- LE N/A
- Fundamental
- Price
- CMPX $1.82
- LE $8.52
- Analyst Decision
- CMPX Strong Buy
- LE Strong Buy
- Analyst Count
- CMPX 8
- LE 2
- Target Price
- CMPX $13.13
- LE $20.00
- AVG Volume (30 Days)
- CMPX 762.7K
- LE 133.3K
- Earning Date
- CMPX 05-08-2025
- LE 06-04-2025
- Dividend Yield
- CMPX N/A
- LE N/A
- EPS Growth
- CMPX N/A
- LE N/A
- EPS
- CMPX N/A
- LE 0.20
- Revenue
- CMPX $850,000.00
- LE $1,362,935,000.00
- Revenue This Year
- CMPX $47.65
- LE $4.26
- Revenue Next Year
- CMPX $2,622.79
- LE $2.67
- P/E Ratio
- CMPX N/A
- LE $41.96
- Revenue Growth
- CMPX N/A
- LE N/A
- 52 Week Low
- CMPX $0.77
- LE $8.15
- 52 Week High
- CMPX $4.08
- LE $19.88
- Technical
- Relative Strength Index (RSI)
- CMPX 46.49
- LE 44.82
- Support Level
- CMPX $1.79
- LE $7.65
- Resistance Level
- CMPX $1.95
- LE $8.61
- Average True Range (ATR)
- CMPX 0.14
- LE 0.48
- MACD
- CMPX 0.01
- LE 0.04
- Stochastic Oscillator
- CMPX 29.52
- LE 54.89
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically, it derives a majority of its revenue from the United States.